Trial Search Results
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
The objective of this study is to better understand the underlying pathogenetic mechanisms of MPDs. We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.
Stanford is currently not accepting patients for this trial.
Inclusion Criteria:Any patient who carries a diagnosis of a myeloproliferative disorder
Exclusion Criteria:Any patient who is not willing to give consent.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study